Analyst Price Targets — SNWV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 7, 2025 11:49 am | Kyle Bauser | Roth Capital | $53.00 | $40.82 | TheFly | Sanuwave Health price target lowered to $53 from $55 at Roth Capital |
| September 3, 2025 12:55 pm | Carl Byrnes | Northland Securities | $55.00 | $40.23 | TheFly | Sanuwave Health initiated with an Outperform at Northland |
| August 22, 2025 11:58 am | Kyle Bauser | Roth Capital | $55.00 | $45.00 | TheFly | Sanuwave Health price target raised to $55 from $54 at Roth Capital |
Latest News for SNWV
SANUWAVE Health, Inc. (SNWV) Q2 2026 Earnings Call Transcript
Sanuwave Health NASDAQ: SNWV reported second-quarter 2026 revenue of $9.7 million, down 3% from $10.1 million a year earlier, as lower UltraMIST system sales offset continued growth in the company's recurring applicator business.
Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025.
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 7, 2026, at 8:30 AM (ET) to present its Q2 2026 financial results.
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenues for the second quarter of 2026 are expected to be in the range of $9.6 to $9.8 million, above the high end of the revised guidance range of $8.5 to $9.5 million provided in the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SNWV.
U.S. House Trading
No House trades found for SNWV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.